Skip to main content
Erschienen in: World Journal of Surgery 9/2014

01.09.2014

Long-Term Quality of Life after Ivor Lewis Esophagectomy for Esophageal Cancer

verfasst von: Silvio Däster, Savas D. Soysal, Lea Stoll, Ralph Peterli, Markus von Flüe, Christoph Ackermann

Erschienen in: World Journal of Surgery | Ausgabe 9/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

Esophagectomy has a potentially high impact on physical, emotional, and social functions. The aim of this study was to assess long-term health-related quality of life (QOL) after esophageal cancer surgery.

Methods

We analyzed all patients who underwent an Ivor Lewis esophagectomy for resectable esophageal cancer in our hospital from 1999 to 2010. QOL was assessed using the European Organization for Research and Treatment of Cancer general questionnaire QLQ-C30 and esophagus-specific questionnaire QLQ-OES18.

Results

A total of 150 patients were operated in the surveyed 12-year period. At the time of analysis, 46 patients (31 %) were eligible for assessment, 97 patients (65 %) had died or experienced tumor recurrence, and seven patients (5 %) were lost to follow-up. Of the 46 eligible patients, 43 (94 %) returned the questionnaires. The median observation interval between the operation and QOL assessment was 40 (range 21–135) months. The QLQ-C30 mean score of global health status and general QOL was similar to that of a healthy reference population. Most of the QLQ-C30 mean scores of functional and symptom scales and QLQ-OES18 symptom scales showed a worse result than for a healthy reference population. The highest mean scores were reflux and eating problems.

Conclusions

In the long term, Ivor Lewis esophagectomy provides a generally good QOL for patients with esophageal cancer, which is comparable to a healthy reference population. However, some patients suffer from significant symptoms. Reflux and eating problems were the most relevant complaints. Dietary counseling is therefore important in the postoperative course.
Literatur
1.
Zurück zum Zitat Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46:765–781PubMedCrossRef Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46:765–781PubMedCrossRef
3.
Zurück zum Zitat Stahl M, Stuschke M, Lehmann N et al (2005) Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23:2310–2317PubMedCrossRef Stahl M, Stuschke M, Lehmann N et al (2005) Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23:2310–2317PubMedCrossRef
4.
Zurück zum Zitat Ariga H, Nemoto K, Miyazaki S et al (2009) Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 75:348–356PubMedCrossRef Ariga H, Nemoto K, Miyazaki S et al (2009) Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 75:348–356PubMedCrossRef
6.
Zurück zum Zitat Biere SS, van Berge Henegouwen MI, Maas KW et al (2012) Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet 379:1887–1892PubMedCrossRef Biere SS, van Berge Henegouwen MI, Maas KW et al (2012) Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet 379:1887–1892PubMedCrossRef
7.
Zurück zum Zitat Mamidanna R, Bottle A, Aylin P et al (2012) Short-term outcomes following open versus minimally invasive esophagectomy for cancer in England: a population-based national study. Ann Surg 255:197–203PubMedCrossRef Mamidanna R, Bottle A, Aylin P et al (2012) Short-term outcomes following open versus minimally invasive esophagectomy for cancer in England: a population-based national study. Ann Surg 255:197–203PubMedCrossRef
8.
Zurück zum Zitat Lewis I (1945) Carcinoma of the oesophagus. Radical resection with oesophago-gastrostomy for a midthoracic growth by a right transpleural approach. Proc R Soc Med 39:483–484 Lewis I (1945) Carcinoma of the oesophagus. Radical resection with oesophago-gastrostomy for a midthoracic growth by a right transpleural approach. Proc R Soc Med 39:483–484
9.
Zurück zum Zitat Blazeby JM, Farndon JR, Donovan J et al (2000) A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer 88:1781–1787PubMedCrossRef Blazeby JM, Farndon JR, Donovan J et al (2000) A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer 88:1781–1787PubMedCrossRef
10.
Zurück zum Zitat de Boer AG, van Lanschot JJ, van Sandick JW et al (2004) Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. J Clin Oncol 22:4202–4208PubMedCrossRef de Boer AG, van Lanschot JJ, van Sandick JW et al (2004) Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. J Clin Oncol 22:4202–4208PubMedCrossRef
11.
Zurück zum Zitat Viklund P, Wengström Y, Rouvelas I et al (2006) Quality of life and persisting symptoms after oesophageal cancer surgery. Eur J Cancer 42:1407–1414PubMedCrossRef Viklund P, Wengström Y, Rouvelas I et al (2006) Quality of life and persisting symptoms after oesophageal cancer surgery. Eur J Cancer 42:1407–1414PubMedCrossRef
12.
Zurück zum Zitat Avery KN, Metcalfe C, Barham CP et al (2007) Quality of life during potentially curative treatment for locally advanced oesophageal cancer. Br J Surg 94:1369–1376PubMedCrossRef Avery KN, Metcalfe C, Barham CP et al (2007) Quality of life during potentially curative treatment for locally advanced oesophageal cancer. Br J Surg 94:1369–1376PubMedCrossRef
13.
Zurück zum Zitat McLarty AJ, Deschamps C, Trastek VF et al (1997) Esophageal resection for cancer of the esophagus: long-term function and quality of life. Ann Thorac Surg 63:1568–1572PubMedCrossRef McLarty AJ, Deschamps C, Trastek VF et al (1997) Esophageal resection for cancer of the esophagus: long-term function and quality of life. Ann Thorac Surg 63:1568–1572PubMedCrossRef
14.
Zurück zum Zitat Deschamps C, Nichols FC, Cassivi SD et al (2005) Long-term function and quality of life after esophageal resection for cancer and Barrett’s. Surg Clin North Am 85:649–656PubMedCrossRef Deschamps C, Nichols FC, Cassivi SD et al (2005) Long-term function and quality of life after esophageal resection for cancer and Barrett’s. Surg Clin North Am 85:649–656PubMedCrossRef
15.
Zurück zum Zitat Moraca RJ, Low DE (2006) Outcomes and health-related quality of life after esophagectomy for high-grade dysplasia and intramucosal cancer. Arch Surg 141:545–549 discussion 549–551PubMedCrossRef Moraca RJ, Low DE (2006) Outcomes and health-related quality of life after esophagectomy for high-grade dysplasia and intramucosal cancer. Arch Surg 141:545–549 discussion 549–551PubMedCrossRef
16.
Zurück zum Zitat Courrech Staal EF, van Sandick JW, van Tinteren H et al (2010) Health-related quality of life in long-term esophageal cancer survivors after potentially curative treatment. J Thorac Cardiovasc Surg 140:777–783PubMedCrossRef Courrech Staal EF, van Sandick JW, van Tinteren H et al (2010) Health-related quality of life in long-term esophageal cancer survivors after potentially curative treatment. J Thorac Cardiovasc Surg 140:777–783PubMedCrossRef
17.
Zurück zum Zitat Derogar M, Lagergren P (2012) Health-related quality of life among 5-year survivors of esophageal cancer surgery: a prospective population-based study. J Clin Oncol 30:413–418PubMedCrossRef Derogar M, Lagergren P (2012) Health-related quality of life among 5-year survivors of esophageal cancer surgery: a prospective population-based study. J Clin Oncol 30:413–418PubMedCrossRef
18.
Zurück zum Zitat Gockel I, Gönner U, Domeyer M et al (2010) Long-term survivors of esophageal cancer: disease-specific quality of life, general health and complications. J Surg Oncol 102:516–522PubMedCrossRef Gockel I, Gönner U, Domeyer M et al (2010) Long-term survivors of esophageal cancer: disease-specific quality of life, general health and complications. J Surg Oncol 102:516–522PubMedCrossRef
19.
Zurück zum Zitat Djärv T, Lagergren J, Blazeby JM et al (2008) Long-term health-related quality of life following surgery for oesophageal cancer. Br J Surg 95:1121–1126PubMedCrossRef Djärv T, Lagergren J, Blazeby JM et al (2008) Long-term health-related quality of life following surgery for oesophageal cancer. Br J Surg 95:1121–1126PubMedCrossRef
20.
Zurück zum Zitat Donohoe CL, McGillycuddy E, Reynolds JV (2011) Long-term health-related quality of life for disease-free esophageal cancer patients. World J Surg 35:1853–1860PubMedCrossRef Donohoe CL, McGillycuddy E, Reynolds JV (2011) Long-term health-related quality of life for disease-free esophageal cancer patients. World J Surg 35:1853–1860PubMedCrossRef
21.
Zurück zum Zitat Gutschow CA, Hölscher AH, Leers J et al (2013) Health-related quality of life after Ivor Lewis esophagectomy. Langenbecks Arch Surg 398:231–237PubMedCrossRef Gutschow CA, Hölscher AH, Leers J et al (2013) Health-related quality of life after Ivor Lewis esophagectomy. Langenbecks Arch Surg 398:231–237PubMedCrossRef
22.
Zurück zum Zitat Siewert JR, Stein HJ (1998) Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 85:1457–1459PubMedCrossRef Siewert JR, Stein HJ (1998) Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 85:1457–1459PubMedCrossRef
23.
Zurück zum Zitat Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376PubMedCrossRef Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376PubMedCrossRef
24.
Zurück zum Zitat Blazeby JM, Alderson D, Winstone K et al (1996) Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. Eur J Cancer 32:1912–1917CrossRef Blazeby JM, Alderson D, Winstone K et al (1996) Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. Eur J Cancer 32:1912–1917CrossRef
25.
Zurück zum Zitat Blazeby JM, Conroy T, Hammerlid E et al (2003) Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer 39:1384–1394PubMedCrossRef Blazeby JM, Conroy T, Hammerlid E et al (2003) Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer 39:1384–1394PubMedCrossRef
26.
Zurück zum Zitat Fayers PM, Aaronson NK, Bjordal K et al (2001) The EORTC QLQ-C30 scoring manual, 3rd edn. EORTC, Brussels Fayers PM, Aaronson NK, Bjordal K et al (2001) The EORTC QLQ-C30 scoring manual, 3rd edn. EORTC, Brussels
27.
Zurück zum Zitat Scott NW, Fayers PM, Aaronson NK et al (2008) EORTC QLQ-C30 reference values. EORTC, Brussels Scott NW, Fayers PM, Aaronson NK et al (2008) EORTC QLQ-C30 reference values. EORTC, Brussels
28.
Zurück zum Zitat Shibuya S, Fukudo S, Shineha R et al (2003) High incidence of reflux esophagitis observed by routine endoscopic examination after gastric pull-up esophagectomy. World J Surg 27:580–583PubMedCrossRef Shibuya S, Fukudo S, Shineha R et al (2003) High incidence of reflux esophagitis observed by routine endoscopic examination after gastric pull-up esophagectomy. World J Surg 27:580–583PubMedCrossRef
29.
Zurück zum Zitat D’Journo XB, Martin J, Rakovich G et al (2009) Mucosal damage in the esophageal remnant after esophagectomy and gastric transposition. Ann Surg 249:262–268PubMedCrossRef D’Journo XB, Martin J, Rakovich G et al (2009) Mucosal damage in the esophageal remnant after esophagectomy and gastric transposition. Ann Surg 249:262–268PubMedCrossRef
30.
Zurück zum Zitat Bemelman WA, Verburg J, Brummelkamp WH et al (1988) A physical model of the intrathoracic stomach. Am J Physiol 254:G168–G175PubMed Bemelman WA, Verburg J, Brummelkamp WH et al (1988) A physical model of the intrathoracic stomach. Am J Physiol 254:G168–G175PubMed
31.
Zurück zum Zitat Johansson J, Oberg S, Wenner J et al (2009) Impact of proton pump inhibitors on benign anastomotic stricture formations after esophagectomy and gastric tube reconstruction: results from a randomized clinical trial. Ann Surg 250:667–673PubMedCrossRef Johansson J, Oberg S, Wenner J et al (2009) Impact of proton pump inhibitors on benign anastomotic stricture formations after esophagectomy and gastric tube reconstruction: results from a randomized clinical trial. Ann Surg 250:667–673PubMedCrossRef
32.
Zurück zum Zitat Urschel JD, Blewett CJ, Young JE et al (2002) Pyloric drainage (pyloroplasty) or no drainage in gastric reconstruction after esophagectomy: a meta-analysis of randomized controlled trials. Dig Surg 19:160–164PubMedCrossRef Urschel JD, Blewett CJ, Young JE et al (2002) Pyloric drainage (pyloroplasty) or no drainage in gastric reconstruction after esophagectomy: a meta-analysis of randomized controlled trials. Dig Surg 19:160–164PubMedCrossRef
33.
Zurück zum Zitat Cerfolio RJ, Bryant AS, Canon CL et al (2009) Is botulinum toxin injection of the pylorus during Ivor Lewis (corrected) esophagogastrectomy the optimal drainage strategy? J Thorac Cardiovasc Surg 137:565–572PubMedCrossRef Cerfolio RJ, Bryant AS, Canon CL et al (2009) Is botulinum toxin injection of the pylorus during Ivor Lewis (corrected) esophagogastrectomy the optimal drainage strategy? J Thorac Cardiovasc Surg 137:565–572PubMedCrossRef
34.
Zurück zum Zitat Swanson EW, Swanson SJ, Swanson RS (2012) Endoscopic pyloric balloon dilatation obviates the need for pyloroplasty at esophagectomy. Surg Endosc 26:2023–2028PubMedCrossRef Swanson EW, Swanson SJ, Swanson RS (2012) Endoscopic pyloric balloon dilatation obviates the need for pyloroplasty at esophagectomy. Surg Endosc 26:2023–2028PubMedCrossRef
35.
36.
Zurück zum Zitat Martin L, Lagergren P (2009) Long-term weight change after oesophageal cancer surgery. Br J Surg 96:1308–1314PubMedCrossRef Martin L, Lagergren P (2009) Long-term weight change after oesophageal cancer surgery. Br J Surg 96:1308–1314PubMedCrossRef
37.
Zurück zum Zitat McKernan M, McMillan DC, Anderson JR et al (2008) The relationship between quality of life (EORTC QLQ-C30) and survival in patients with gastro-oesophageal cancer. Br J Surg 98:888–893 McKernan M, McMillan DC, Anderson JR et al (2008) The relationship between quality of life (EORTC QLQ-C30) and survival in patients with gastro-oesophageal cancer. Br J Surg 98:888–893
Metadaten
Titel
Long-Term Quality of Life after Ivor Lewis Esophagectomy for Esophageal Cancer
verfasst von
Silvio Däster
Savas D. Soysal
Lea Stoll
Ralph Peterli
Markus von Flüe
Christoph Ackermann
Publikationsdatum
01.09.2014
Verlag
Springer US
Erschienen in
World Journal of Surgery / Ausgabe 9/2014
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-014-2576-1

Weitere Artikel der Ausgabe 9/2014

World Journal of Surgery 9/2014 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.